Use of Dipeptidyl Peptidase 4 (DPP4) Inhibitors in Diabetic Nephropathy: A Prospective Cohort Study. Medical Forum Monthly, [S. l.], v. 36, n. 9, 2025. DOI: 10.60110/medforum.360904. Disponível em: https://medicalforummonthly.com/index.php/mfm/article/view/5397.. Acesso em: 26 dec. 2025.